What do an Epstein-Barr virus viral capsid antigen (VCA) level of 26.30 and an Epstein-Barr virus nuclear antigen (EBNA) level of 149 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EBV Serological Interpretation: VCA 26.30 and EBNA 149

These results indicate a past EBV infection that occurred more than 6-8 weeks ago, not an acute or recent infection. The presence of both VCA antibodies and EBNA antibodies together is the hallmark serological pattern of remote EBV exposure 1.

What These Numbers Mean

Your results show:

  • VCA (Viral Capsid Antigen) = 26.30: This is positive, indicating exposure to EBV at some point
  • EBNA (EBV Nuclear Antigen) = 149: This is positive, indicating the infection occurred at least 1-2 months ago

Clinical Interpretation Algorithm

The presence of EBNA antibodies is the key finding here. According to IDSA/ASM guidelines, EBNA antibodies develop 1-2 months or more after primary EBV infection and remain detectable for life 1. This timing is critical for interpretation:

If You Have Current Symptoms:

EBV is NOT the cause of your current illness. The presence of EBNA antibodies indicates infection more than 6 weeks from the time of sample collection, therefore not implicating EBV as the cause of acute symptoms 1.

If you're experiencing mononucleosis-like symptoms now, other causes should be investigated including:

  • Cytomegalovirus (CMV)
  • HIV
  • Toxoplasma gondii
  • Adenovirus

If You Have No Current Symptoms:

This represents normal past exposure to EBV, which is extremely common. Over 90% of the normal adult population has IgG antibodies to both VCA and EBNA antigens 1.

What's Missing from Your Results

The critical missing piece is VCA IgM status. The complete interpretation requires knowing whether VCA IgM is present or absent 1:

  • VCA IgM absent + VCA IgG present + EBNA present = Past infection (most likely your situation)
  • VCA IgM present + EBNA absent = Recent primary infection (acute mononucleosis)
  • VCA IgM present + EBNA present = Either late primary infection OR reactivation (requires additional testing like IgG avidity to differentiate) 2

Important Caveats

Note that 5-10% of people who have been infected with EBV fail to develop EBNA antibodies 1. However, since your EBNA is clearly positive at 149, this doesn't apply to you.

The numerical values you provided (26.30 and 149) appear to be assay-specific units. Different laboratories use different cutoffs and measurement systems, so these absolute numbers are less important than whether they fall above or below your laboratory's positive threshold.

Bottom Line

You have serological evidence of past EBV infection that is not causing current symptoms. If you're being tested because of current illness, EBV should be ruled out as the cause, and alternative diagnoses should be pursued. If this was routine testing, no action is needed—this is a normal finding in the majority of adults.

Related Questions

What does an abnormal EBV viral capsid antigen IgM, reactive EBV viral capsid antigen IgG, and non‑reactive EBV nuclear antigen IgG indicate?
What does a positive Epstein‑Barr virus (EBV) capsid antigen IgG (7.5 AU), positive EBV nuclear antigen IgG (>8.0 AU), and low EBV early antigen D IgG (1.9 AU) result indicate, and what are the next clinical steps?
What does a rising Epstein‑Barr virus IgG level with IgM below the laboratory cutoff (<10 U/mL) indicate about infection status and recommended management?
What are the various Epstein‑Barr virus antibodies (viral capsid antigen IgM, viral capsid antigen IgG, Epstein‑Barr nuclear antigen IgG, early antigen IgG) and when do they typically develop during infection?
Given Epstein‑Barr virus (EBV) serology with negative viral capsid antigen (VCA) immunoglobulin M (IgM), high‑titer VCA immunoglobulin G (IgG), positive EBV nuclear antigen‑1 (EBNA‑1) IgG, and strongly positive early‑antigen D (EA‑D) IgG, what is the appropriate next step in management?
What are the current standard treatment recommendations for limited-stage and extensive-stage small cell lung cancer, including consolidation immunotherapy and second-line options?
What are the indications for pentoxifylline?
Is a daily dose of nortriptyline 100 mg appropriate for an 81‑year‑old patient?
What is the appropriate evaluation for a patient with tropical splenomegaly?
Is fexofenadine (an antihistamine) safe to use during pregnancy?
Can you interpret the patient's laboratory results, which show a mild macrocytosis and borderline high LDL cholesterol, while all other parameters are within normal limits?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.